Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country
Phase 1
Study type
102 / 777 trials
PostedSponsorStudyPhaseStatus
3 Nov 2026Antev Ltd.PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine CorrelatesPhase 2Not Yet Recruiting3 Nov 2026Arjil Pharmaceuticals LLCTaiwanA Study for AR100DP1 in Mild to Moderate Atopic DermatitisPhase 2Recruiting3 Nov 2026Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.ChinaStudy of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)Phase 2Not Yet Recruiting3 Nov 2026BeOne MedicinesStudy Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular CarcinomaPhase 2Not Yet Recruiting3 Nov 2026Coultreon BiopharmaCanadaA Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque PsoriasisPhase 2Not Yet Recruiting3 Nov 2026Gilead SciencesStudy to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital HerpesPhase 2Not Yet Recruiting3 Nov 2026Grünenthal GmbHA Trial to Investigate the Efficacy and Safety of Tegacorat in Male Participants 4 to <7 Years of Age With Duchenne Muscular DystrophyPhase 2Not Yet Recruiting3 Nov 2026InnovStone Therapeutics LimitedA Study Evaluating the Efficacy and Safety of SYH2072 Tablets In Hypertensive PatientsPhase 2Not Yet Recruiting3 Nov 2026Sinfatin S.LSpainRimonabant for Improving Walking Ability in Patients With Chronic StrokePhase 2Not Yet Recruiting3 Nov 2026Tavo BiotherapeuticsUnited StatesA Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.Phase 2Recruiting2 Nov 2026Cristcot LLCA Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 2 Study to Evaluate the Safety and Efficacy of Two Dosage Regimens of a Novel Hydrocortisone Acetate Suppository Formulation Administered With a Proprietary Suppository Applicator in Subjects With Hemorrhoidal DiseasePhase 2Not Yet Recruiting2 Nov 2026Jiangsu Jingze Biopharmaceutical Co., Ltd.ChinaA Study Evaluating the Efficacy and Safety of Recombinant Human Truncated Plasmin Injection (JZB32) in Patients With Vitreomacular TractionPhase 2Recruiting2 Nov 2026Shanghai Huaota Biopharmaceutical Co., Ltd.ChinaA Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary FibrosisPhase 2Not Yet Recruiting30 Oct 2026Juro Sciences Inc.JapanA Proof-Of-Concept (POC) Study of SFG-02 Transdermal Formulation in Participants With Underactive Bladder (UAB)Phase 2Recruiting30 Oct 2026Pelage Pharmaceuticals, Inc.United StatesPhase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic AlopeciaPhase 2Recruiting29 Oct 2026AbbViePlatform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid ArthritisPhase 2Not Yet Recruiting29 Oct 2026Aperta Biosciences, LLCGuatemalaA Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With BlepharitisPhase 2Not Yet Recruiting29 Oct 2026Otsuka Pharmaceutical Development & Commercialization, Inc.Trial of VIS954 in the Treatment of Antineutrophil Cytoplasmic Antibody-associated VasculitisPhase 2Not Yet Recruiting29 Oct 2026Vigonvita Life SciencesChinaA Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's DiseasePhase 2Not Yet Recruiting29 Oct 2026X4 PharmaceuticalsA Study to Investigate the Safety and Tolerability of Granulocyte-colony Stimulating Factor (G-CSF) Dosage Reduction in Mavorixafor-treated Participants With Acquired Primary Autoimmune and Idiopathic Chronic Neutropenia DisordersPhase 2Not Yet Recruiting28 Oct 2026Alkermes, Inc.United StatesA Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive DisorderPhase 2Recruiting28 Oct 2026Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.ChinaThis Study Will Evaluate the Effect and Safety of 626 in Patients With CLEPhase 2Not Yet Recruiting27 Oct 2026Invivyd, Inc.Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination SyndromePhase 2Not Yet Recruiting27 Oct 2026T-MAXIMUM Pharmaceutical IncUnited States, TaiwanThe METAMAX Study: MT027 Allogeneic CAR-T for Brain Metastases From Advanced Solid TumorsPhase 2Not Yet Recruiting26 Oct 2026AbbVieA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Alveltamig and Atezolizumab for Adults Participants With Extensive Stage-Small Cell Lung CancerPhase 2Not Yet Recruiting26 Oct 2026AbbVieA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Tarlatamab and Atezolizumab in Adult Participants With Extensive Stage-Small Cell Lung CancerPhase 2Not Yet Recruiting26 Oct 2026AeroRx Therapeutics Inc.United KingdomPhase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD PatientsPhase 2Recruiting26 Oct 2026Changchun BCHT Biotechnology Co.ChinaA Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Phase 2Recruiting26 Oct 2026Healthgen Biotechnology Corp.Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa.Phase 2Not Yet Recruiting26 Oct 2026Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.ChinaPhase II Clinical Study to Evaluate the Efficacy and Safety of LT-002-158 Tablets in Adult Patients With Moderate-to-Severe Atopic DermatitisPhase 2Recruiting26 Oct 2026Merck Sharp & Dohme LLCA Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)Phase 2Not Yet Recruiting26 Oct 2026RemeGen Co., Ltd.ChinaPhase II Clinical Study of RC148 (ABBV-1480) in Combination With Telisotuzumab Adizutecan (With or Without Chemotherapy) for Unresectable Colorectal CancerPhase 2Not Yet Recruiting23 Oct 2026AN2 Therapeutics, IncAustraliaPhase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraPhase 2Not Yet Recruiting23 Oct 2026Hikma Pharmaceuticals USA Inc.United StatesPharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy PatientsPhase 2Not Yet Recruiting23 Oct 2026McNeil ABCanadaA Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker VolunteersPhase 2Recruiting23 Oct 2026Sunshine Lake Pharma Co., Ltd.ChinaHEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesPhase 2Not Yet Recruiting22 Oct 2026Beijing Keymed Biosciences Co., Ltd.ChinaStudy of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background TherapyPhase 2Not Yet Recruiting22 Oct 2026BiogenA Study to Learn About the Effects of Felzartamab on the Kidneys of Adults With Immunoglobulin A Nephropathy (IgAN)Phase 2Not Yet Recruiting22 Oct 2026Edesa Biotech Inc.Canada, PanamaA Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental VitiligoPhase 2Recruiting22 Oct 2026Eli Lilly and CompanyUnited States, ArgentinaA Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesPhase 2Not Yet Recruiting22 Oct 2026Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.ChinaA Phase II Study of FXR0906 in Patients With Severe Hypertriglyceridemia or Hypertriglyceridemia With ASCVD.Phase 2Not Yet Recruiting22 Oct 2026Jiangsu Guiqiong Pharmaceutical Co., Ltd.ChinaA Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer CachexiaPhase 2Not Yet Recruiting22 Oct 2026Lumosa Therapeutics Co., Ltd.TaiwanA Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS ParticipantPhase 2Recruiting22 Oct 2026Pharmasaga Co. Ltd.A Phase 2 Two-Part Study of Oral PS1 in Healthy Volunteers and Adults With Newly Diagnosed Type 1 DiabetesPhase 2Not Yet Recruiting22 Oct 2026SPH Sine Pharmaceutical Laboratories Co., Ltd.ChinaWST03 Capsule Combined With Metronidazole for Bacterial VaginosisPhase 2Not Yet Recruiting21 Oct 2026IRulya Therapeutics Inc.United StatesLAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)Phase 2Not Yet Recruiting21 Oct 2026Tarsus Pharmaceuticals, Inc.United States, Dominican Republic, El SalvadorA Study to Evaluate the Efficacy and Safety of TP-06 for PCEDPhase 2Recruiting20 Oct 2026AkesoA Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.Phase 2Not Yet Recruiting20 Oct 2026CSPC Ouyi Pharmaceutical Co., Ltd.ChinaPhase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection.Phase 2Not Yet Recruiting20 Oct 2026EktaHTunisiaA PHASE 2A, EXPLORATORY, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN OBESE ADULTS.Phase 2Not Yet Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.